Clinical Trial Update: Effect of Topiroxostat on Urinary Albumin Excretion Early Stage Diabetic Nephropathy and Hyperuricemia With or Without Gout [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the effect of topiroxostat on urinary albumin excretion in early-stage diabetic nephropathy with hyperuricemia, with or withou…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Gout
• Hyperuricemia

Drugs mentioned

• Topiroxostat (topiroxostat)

Snippet

Sponsor: Sanwa Kagaku Kenkyusho Co., Ltd. | Conditions: Diabetic Nephropathy | Phase 2 | Status: COMPLETED